Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Receives $10.00 Consensus Target Price from Analysts
Shares of Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Get Free Report) have been given an average recommendation of “Buy” by the eight analysts that are currently covering the stock, Marketbeat.com reports. Seven research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 […]
Shares of Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Get Free Report) have been given an average recommendation of “Buy” by the eight analysts that are currently covering the stock, Marketbeat.com reports. Seven research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 […]
